DarioHealth closes $22.4M preferred stock offering with Aegis Capital

DarioHealth Corp.

Closed offering of Series C, C-1, C-2 Preferred Stock on Feb 21, 2024.
Aggregate gross proceeds of approximately $22,422,000.
Aegis Capital Corp. acted as placement agent.
No further closings are planned for the offering.

item 8.01

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-24-029961

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.